How Denial and Appeal Analytics Reveal True Payer Performance

Gain deeper visibility into payer behavior with analytics that help laboratories reduce denials, recover revenue, and improve collections.

Healthcare organizations invest significant time and resources negotiating payer contracts, often focusing heavily on reimbursement rates. But as many laboratories and healthcare providers discover, a favorable fee schedule does not automatically translate into favorable reimbursement outcomes.

During a recent webinar, Ann Lambrix, Executive Director of RCM Consulting at Lighthouse Lab Services, and Gene Oberst, Senior Analyst of Business Intelligence and Reimbursement Management at Quadax, encouraged laboratory leaders to rethink how they evaluate payer contracts.

The industry's traditional focus on fee schedules and negotiated rates often overlooks the factors that have the greatest impact on financial performance, including coverage policies, administrative burden, denial rates, and payment accuracy.

As the speakers emphasized: The most important number in any payer contract is not the negotiated reimbursement rate. It is the amount the laboratory actually collects.

Reimbursement Does Not Equal Coverage

One of the most common misconceptions in payer contracting is that an approved CPT code and a negotiated rate automatically mean claims will be paid. In reality, coverage policies often determine whether reimbursement occurs at all.

"When you're doing contracting, the key is setting expectations, monitoring the KPIs, identifying opportunities, and getting to the root cause of why you're not getting paid," said Oberst.

Laboratories must evaluate factors such as:

• Medical necessity requirements

• Covered diagnosis limitations

• Prior authorization mandates

• Site-of-service restrictions

• Network participation rules

• MolDx and Z-Code requirements, where applicable

A contract may appear attractive during negotiations, but if administrative requirements consistently prevent claims from being paid, the expected financial return quickly erodes.

Evaluate the Full Business Impact

Before entering a payer agreement, laboratories should assess more than reimbursement percentages.

Key questions include:

• How much of the organization's volume comes from this payer?

• What impact will the contract have on overall revenue and market access?

• Does the reimbursement methodology align with the laboratory's highest-volume CPT codes?

• What operational burden will be required to secure payment?

For example, a payer may offer an attractive percentage of the Medicare Physician Fee Schedule, but many laboratory services are reimbursed under the Clinical Laboratory Fee Schedule. Without understanding how the contract applies to the lab's actual test mix, financial projections can be misleading.

Administrative Requirements Have Real Costs

The operational burden associated with payer requirements is often overlooked during negotiations.

Prior authorizations, medical record requests, and documentation reviews can create significant friction across the revenue cycle by:

• Increasing staffing demands

• Adding manual workflows

• Delaying testing and reimbursement

• Driving denial rates higher

These costs may not appear in the contract itself, but they directly impact profitability and should be factored into any evaluation of payer performance.

Continuous Monitoring Is Essential

Signing a contract is only the beginning. Even well-negotiated agreements can fail to deliver expected results due to contract loading errors, adjudication issues, policy changes, or underpayments.

To ensure payer performance aligns with contractual expectations, laboratories should regularly monitor:

• Expected versus actual reimbursement

• Denial rates and denial categories

• Appeal success rates

• Prior authorization outcomes

• Days Sales Outstanding (DSO)

• Average Sales Price (ASP)

• Net Collection Rate (NCR)

These metrics help identify revenue leakage, operational inefficiencies, and payer-specific issues before they significantly affect cash flow.

Turning Data Into Action

Denial and payment analytics provide critical insight into whether contract performance issues originate with the payer or internal processes. Contract variance reporting can uncover underpayments, while denial trends can reveal recurring authorization, documentation, or coverage challenges.

"We've done all this due diligence upfront, but if you're not looking at your denials and actual payments and comparing them to your expectations, there's a lack of visibility on the back end to make sure that contract is healthy," said Lambrix.

Just as importantly, analytics give laboratories the data needed to hold payers accountable. When reimbursement does not align with contracted terms, detailed reporting provides the evidence necessary to escalate issues and drive resolution.

The Bottom Line

The most valuable payer contracts are not necessarily those with the highest reimbursement rates. They are the contracts that consistently produce timely payment with minimal administrative burden.

By looking beyond the fee schedule and leveraging denial analytics, payment reporting, and contract performance metrics, laboratory leaders can gain a clearer picture of payer performance, reduce revenue leakage, and maximize the long-term value of their payer relationships.

Want to learn how leading laboratories are using denial, appeal, and payment analytics to evaluate payer performance and improve reimbursement outcomes?

Watch the on-demand webinar to gain deeper insights into payer contracting strategy, revenue cycle optimization, and the metrics that reveal the true value of payer relationships.